The federal government has uncovered a dramatic surge in Medicare claims for skin substitutes, known as allografts, rising by 7,100% between 2019 and 2025. Payments for these treatments increased from $200 million to $14.4 billion during the same period, prompting a nationwide investigation into potential fraud.
Leaders of the anti-fraud task force, established to combat systemic abuses in federal healthcare programs, have denied 96% of claims submitted since March. The Centers for Medicare and Medicaid Services identified 4,200 suspicious allograft claims totaling $224 million as of May 2025. Officials emphasized the financial strain on healthcare systems, warning of broader consequences for patients and providers.
Efforts to address fraudulent billing have extended to durable medical equipment (DME), including wheelchairs and hospital beds. Payments to 102 suppliers have been suspended, and billing privileges revoked for 725 additional companies. These suppliers accounted for 8.6% of all Medicare-funded DME transactions in 2025. Investigators identified fraudulent patterns such as claims for unnecessary equipment, exaggerated costs, and undelivered products.
Administrators credited a coordinated federal strategy with dismantling major fraud networks. Over $220 million in fraudulent skin substitute claims have been blocked, and enforcement actions have targeted hundreds of DME suppliers. Officials issued warnings to potential offenders, stating, “Fraud undermines trust and destabilizes critical healthcare services.”
Recent actions include the Justice Department’s arrest of 15 individuals in Minnesota linked to over $90 million in fraudulent state program claims. Authorities highlighted these cases as part of a broader initiative to eliminate systemic abuse in public assistance programs. The task force has also pursued high-profile Medicaid and autism-related fraud schemes, declaring a commitment to “eradicate corruption through relentless accountability.”
Launched in May via executive order, the task force has mobilized multiple agencies to identify and prosecute fraudulent activity. Government officials have cited early successes, noting “billions recovered and thousands of bad actors held responsible.” Continued efforts focus on safeguarding taxpayer funds while ensuring vulnerable populations receive proper care without interference from criminal enterprises.
